Resultats de la cerca - Matthias Pfisterer
- Mostrar 1 - 20 resultats de 36
- Anar a la pàgina següent
-
1
-
2
Raised cardiac troponins per Peter Ammann, Matthias Pfisterer, Thomas Fehr, Hans Rickli
Publicat 2004Editorial -
3
-
4
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel antiarrhythmic study of infarct surviva... per F Burkart, Matthias Pfisterer, W Kiowski, Ferenc Folláth, D Burckhardt
Publicat 1990Artigo -
5
-
6
Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence per Ines Arrigo, Hans‐Peter Brunner‐La Rocca, Michael Lefkovits, Matthias Pfisterer, Andreas Hoffmann
Publicat 2008Artigo -
7
Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial per Thilo Burkard, Christoph Kaiser, Hans‐Peter Brunner‐La Rocca, Stefan Osswald, Matthias Pfisterer, Raban Jeger
Publicat 2011Artigo -
8
Prevention of Supraventricular Tachyarrhythmias After Open Heart Operation by Low-Dose Sotalol: A Prospective, Double-Blind, Randomized, Placebo-Controlled Study per Matthias Pfisterer, Uta C.D Klöter-Weber, Maurus Huber, Stefan Osswald, Peter Buser, K. Skarvan, P Stulz
Publicat 1997Artigo -
9
Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coron... per Miodrag Filipovic, Raban Jeger, C Probst, Thierry Girard, Matthias Pfisterer, Lorenz Gürke, K. Skarvan, Manfred D. Seeberger
Publicat 2003Artigo -
10
-
11
-
12
Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms per Thomas H. Schindler, Burkhard Hornig, Peter Buser, Manfred Olschewski, Nobuhisa Magosaki, Matthias Pfisterer, Egbert Nitzsche, U. Solzbach, H. Just
Publicat 2003Artigo -
13
Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction per Sandra Sanders‐van Wijk, Vanessa van Empel, Nasser Davarzani, Micha T. Maeder, Rolf Handschin, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Publicat 2015Artigo -
14
Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congesti... per Peter Rickenbacher, Beat A. Kaufmann, Micha T. Maeder, Alain Bernheim, Kaatje Goetschalckx, Otmar Pfister, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Publicat 2017Artigo -
15
Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET per Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca, Peter Rickenbacher, Patrick Hunziker, Christian Mueller, F. Nietlispach, Gregor Leibundgut, Franziska Bader, Christoph Kaiser
Publicat 2008Artigo -
16
Frequency and Predictors of Hyperkalemia in Patients ≥60 Years of Age With Heart Failure Undergoing Intense Medical Therapy per Stefano Muzzarelli, Micha T. Maeder, Stefan Toggweiler, Hans Rickli, Fabian Nietlispach, Barbara Julius, Thilo Burkard, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Publicat 2011Artigo -
17
Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel Interventions per Raban Jeger, Stefan Schneiter, Christoph Kaiser, Piero O. Bonetti, Hans‐Peter Brunner‐La Rocca, Michael Handke, Stefan Osswald, Peter Buser, Matthias Pfisterer
Publicat 2008Artigo -
18
Impact of worsening renal function related to medication in heart failure per Hans‐Peter Brunner‐La Rocca, Christian Knackstedt, Luc W.M. Eurlings, Vinzent Rolny, Friedemann Krause, Matthias Pfisterer, Daniel Tobler, Peter Rickenbacher, Micha T. Maeder
Publicat 2014Artigo -
19
Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF) randomized... per Marjolein Huijts, Robert J. van Oostenbrugge, Annelien Duits, Thilo Burkard, Stefano Muzzarelli, Micha T. Maeder, Ruth Schindler, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Publicat 2013Artigo -
20
N‐terminal pro brain natriuretic peptide‐guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Me... per Micha T. Maeder, Peter Rickenbacher, Hans Rickli, Heidi Abbühl, Marc Gutmann, Paul Erné, André Vuilliomenet, Martin G. Peter, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Publicat 2013Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Cardiology
Myocardial infarction
Heart failure
Confidence interval
Coronary artery disease
Ejection fraction
Surgery
Randomized controlled trial
Hazard ratio
Natriuretic peptide
Odds ratio
Percutaneous coronary intervention
Stent
Drug-eluting stent
Restenosis
Anesthesia
Artery
Bare metal
Blood pressure
Nursing
Revascularization
Asymptomatic
Atrial fibrillation
Bare-metal stent
Coronary arteries
Creatinine
Heart failure with preserved ejection fraction
Heart rate